{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:14:35Z","timestamp":1771654475772,"version":"3.50.1"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T00:00:00Z","timestamp":1414454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110545","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T17:56:34Z","timestamp":1414518994000},"page":"e110545","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines"],"prefix":"10.1371","volume":"9","author":[{"given":"Tomer","family":"Israely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagit","family":"Achdout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noam","family":"Erez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boaz","family":"Politi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Waner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Paran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,10,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/clinids\/4.5.916","article-title":"A successful eradication campaign. Global eradication of smallpox","volume":"4","author":"F Fenner","year":"1982","journal-title":"Rev Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"DA Henderson","year":"1999","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1086\/374054","article-title":"Can postexposure vaccination against smallpox succeed?","volume":"36","author":"PP Mortimer","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref4","unstructured":"Cross J (1821) A history of the variolous epidemic which occurred in Norwich, in the year 1819, and destroyed 530 individuals; with an estimate of the protection afforded by vaccination, and a review of past and present opinions upon chicken-pox and modified smallpox.; J EM, editor."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-61779-876-4_11","article-title":"Mousepox, a small animal model of smallpox","volume":"890","author":"D Esteban","year":"2012","journal-title":"Methods Mol Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","article-title":"Ectromelia virus: the causative agent of mousepox","volume":"86","author":"DJ Esteban","year":"2005","journal-title":"J Gen Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1743-422X-9-119","article-title":"A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease","volume":"9","author":"T Israely","year":"2012","journal-title":"Virol J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/595565","article-title":"Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox","volume":"199","author":"N Paran","year":"2009","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/JVI.02012-09","article-title":"A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus","volume":"84","author":"J Stabenow","year":"2010","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2007.08.003","article-title":"Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model","volume":"77","author":"S Parker","year":"2008","journal-title":"Antiviral Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice","volume":"51","author":"DC Quenelle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.vaccine.2009.01.038","article-title":"Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response","volume":"27","author":"S Lustig","year":"2009","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"SG Reed","year":"2013","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"T Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/08830185.2013.774391","article-title":"Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors","volume":"32","author":"M Sasai","year":"2013","journal-title":"Int Rev Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","article-title":"Toll-like receptors in antiviral innate immunity","volume":"426","author":"SN Lester","year":"2014","journal-title":"J Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coviro.2011.10.006","article-title":"Toll-like receptors: key players in antiviral immunity","volume":"1","author":"N Arpaia","year":"2011","journal-title":"Curr Opin Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2147\/IJN.S30197","article-title":"Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system","volume":"7","author":"N Hanagata","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.smim.2009.05.006","article-title":"The innate immune response to DNA","volume":"21","author":"A Vilaysane","year":"2009","journal-title":"Semin Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","article-title":"TLR3: interferon induction by double-stranded RNA including poly(I:C)","volume":"60","author":"M Matsumoto","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/BJ20131492","article-title":"Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses","volume":"458","author":"M Tatematsu","year":"2014","journal-title":"Biochem J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.coi.2012.11.001","article-title":"TLR3 immunity to infection in mice and humans","volume":"25","author":"SY Zhang","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"F Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.vaccine.2008.12.048","article-title":"A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic","volume":"27","author":"YF Lau","year":"2009","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1000373","DOI":"10.1371\/journal.ppat.1000373","article-title":"Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques","volume":"5","author":"C Stahl-Hennig","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2009.07.058","article-title":"Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine","volume":"28","author":"I Skountzou","year":"2010","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1016\/j.vaccine.2011.05.001","article-title":"Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)","volume":"29","author":"DN Taylor","year":"2011","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1586\/erv.10.60","article-title":"TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine","volume":"9","author":"C Coban","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Tougan T, Aoshi T, Coban C, Katakai Y, Kai C, et al.. (2013) TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36\/AHG malaria vaccine in nonhuman primate models. Hum Vaccin Immunother 9.","DOI":"10.4161\/hv.22950"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1586\/14760584.6.2.133","article-title":"New hepatitis B vaccine formulated with an improved adjuvant system","volume":"6","author":"M Kundi","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"AM Didierlaurent","year":"2009","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2006.10.009","article-title":"A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost","volume":"25","author":"Y Xiao","year":"2007","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.vaccine.2006.12.037","article-title":"Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges","volume":"25","author":"CN Fogg","year":"2007","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e42353","DOI":"10.1371\/journal.pone.0042353","article-title":"Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates","volume":"7","author":"JW Golden","year":"2012","journal-title":"PLoS One"},{"key":"ref35","first-page":"750","article-title":"Antibody in tears following intranasal vaccination with inactivated virus. II. Enhancement of tear antibody production by the use of polyinosinic: polycytidilic acid (poly I:C)","volume":"10","author":"HL Knopf","year":"1971","journal-title":"Invest Ophthalmol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"C Samuelsson","year":"2008","journal-title":"J Clin Invest"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1099\/vir.0.055921-0","article-title":"Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity","volume":"94","author":"GL Smith","year":"2013","journal-title":"J Gen Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e1002475","DOI":"10.1371\/journal.ppat.1002475","article-title":"Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver","volume":"8","author":"RH Xu","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1743-422X-10-229","article-title":"Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response","volume":"10","author":"N Paran","year":"2013","journal-title":"Virol J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e1002557","DOI":"10.1371\/journal.ppat.1002557","article-title":"Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox","volume":"8","author":"M Kremer","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref41","unstructured":"Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoint. Am J Hyg 493\u2013497."},{"key":"ref42","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.0405954101","article-title":"Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox","volume":"101","author":"PB Jahrling","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF01990501","article-title":"The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses","volume":"45","author":"A Jurado","year":"1989","journal-title":"Experientia"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.139.3.767","article-title":"Inhibition of B lymphocyte activation by interferon-gamma","volume":"139","author":"DS Reynolds","year":"1987","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"GW Buchman","year":"2010","journal-title":"Vaccine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection","volume":"79","author":"T Ichinohe","year":"2005","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.vaccine.2012.11.007","article-title":"Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide\/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge","volume":"31","author":"Y Xiao","year":"2013","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20071854","article-title":"The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination","volume":"205","author":"RH Xu","year":"2008","journal-title":"J Exp Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0928-8244(03)00358-4","article-title":"Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma","volume":"40","author":"G Liu","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"U Muller","year":"1994","journal-title":"Science"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.1992.tb01413.x","article-title":"Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo","volume":"127","author":"I Ramshaw","year":"1992","journal-title":"Immunol Rev"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/infdis\/137.1.78","article-title":"Topical treatment of vaccinia virus infection with an interferon inducer in rabbits","volume":"137","author":"HB Levy","year":"1978","journal-title":"J Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Walsh KB, Teijaro JR, Brock LG, Fremgen DM, Collins PL, et al.. (2014) Animal model of respiratory syncytial virus: CD8+ T cells cause cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy. J Virol.","DOI":"10.1128\/JVI.00464-14"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e77879","DOI":"10.1371\/journal.pone.0077879","article-title":"Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses","volume":"8","author":"SA Holechek","year":"2013","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1128\/JVI.00162-12","article-title":"Lethal monkeypox virus infection of CAST\/EiJ mice is associated with a deficient gamma interferon response","volume":"86","author":"PL Earl","year":"2012","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"IM Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.1200799","article-title":"CD8 T cells are essential for recovery from a respiratory vaccinia virus infection","volume":"189","author":"J Goulding","year":"2012","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Volz A, Langenmayer M, Jany S, Kalinke U, Sutter G (2014) Rapid expansion of CD8+ T cells in wildtype and type I interferon receptor deficient mice correlates with protection after low-dose emergency immunization with Modified Vaccinia virus Ankara. J Virol.","DOI":"10.1128\/JVI.00945-14"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T17:09:46Z","timestamp":1689613786000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110545"}},"subtitle":[],"editor":[{"given":"Joseph J.","family":"Mattapallil","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,28]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110545","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,28]]}}}